Ivan J. Stone

2.4k total citations
33 papers, 1.6k citations indexed

About

Ivan J. Stone is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ivan J. Stone has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Ivan J. Stone's work include Monoclonal and Polyclonal Antibodies Research (20 papers), HER2/EGFR in Cancer Research (14 papers) and Lymphoma Diagnosis and Treatment (9 papers). Ivan J. Stone is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), HER2/EGFR in Cancer Research (14 papers) and Lymphoma Diagnosis and Treatment (9 papers). Ivan J. Stone collaborates with scholars based in United States, Netherlands and Canada. Ivan J. Stone's co-authors include Lori Westendorf, Iqbal S. Grewal, Peter D. Senter, Kristine A. Gordon, Robert P. Lyon, Ezogelin Oflazoglu, Scott C. Jeffrey, Charlotte F. McDonagh, Stephen C. Alley and Nicole M. Okeley and has published in prestigious journals such as Blood, Nature Biotechnology and Cancer Research.

In The Last Decade

Ivan J. Stone

33 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ivan J. Stone United States	17	1.0k	926	564	304	163	33	1.6k
Maureen Dougher United States	14	587 0.6×	433 0.5×	345 0.6×	132 0.4×	94 0.6×	24	1.0k
Michael Torgov United States	11	983 1.0×	941 1.0×	639 1.1×	136 0.4×	32 0.2×	19	1.6k
Stefan Knackmuss Germany	23	660 0.6×	640 0.7×	534 0.9×	485 1.6×	97 0.6×	41	1.4k
Jay Harper United States	18	673 0.7×	267 0.3×	696 1.2×	157 0.5×	72 0.4×	34	1.4k
Benno Rattel Germany	17	804 0.8×	469 0.5×	452 0.8×	459 1.5×	257 1.6×	36	1.3k
Fiona E. Smyth Australia	23	625 0.6×	622 0.7×	526 0.9×	261 0.9×	44 0.3×	39	1.3k
Julie A. McEarchern United States	13	537 0.5×	294 0.3×	387 0.7×	384 1.3×	158 1.0×	25	1.0k
Kendall D. Carey United States	10	1.1k 1.0×	651 0.7×	951 1.7×	330 1.1×	37 0.2×	12	1.9k
Kim M. Kissler United States	7	895 0.9×	929 1.0×	434 0.8×	179 0.6×	18 0.1×	11	1.3k
Matthew J. Bernett United States	16	464 0.5×	400 0.4×	418 0.7×	366 1.2×	298 1.8×	40	1.2k

Countries citing papers authored by Ivan J. Stone

Since Specialization

Citations

This map shows the geographic impact of Ivan J. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan J. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan J. Stone more than expected).

Fields of papers citing papers by Ivan J. Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan J. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan J. Stone. The network helps show where Ivan J. Stone may publish in the future.

Co-authorship network of co-authors of Ivan J. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan J. Stone. A scholar is included among the top collaborators of Ivan J. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan J. Stone. Ivan J. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xinqun, Roma Yumul, Weiping Zeng, et al.. (2019). A coiled-coil masking domain for selective activation of therapeutic antibodies. Nature Biotechnology. 37(7). 761–765. 64 indexed citations

Li, Fu, Michelle Ulrich, Mechthild Jonas, et al.. (2017). Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 16(7). 1347–1354. 53 indexed citations

Krishnamoorthy, Sriram, Betty S. Pace, Dipti Gupta, et al.. (2017). Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease. JCI Insight. 2(20). 36 indexed citations

Burke, Patrick, Scott C. Jeffrey, Joshua H. Hunter, et al.. (2016). Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 16(1). 116–123. 110 indexed citations

Burke, Patrick, Jocelyn R. Setter, Joshua H. Hunter, et al.. (2016). Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 15(5). 938–945. 45 indexed citations

Epps, Heather A. Van, Ryan A. Heiser, Anthony Cao, et al.. (2016). Denintuzumab Mafodotin Stimulates Immune Responses and Synergizes with CD20 Antibodies to Heighten Anti-Tumor Activity in Preclinical Models of Non-Hodgkin Lymphoma. Blood. 128(22). 4177–4177. 2 indexed citations

Sandall, Sharsti, Martha E. Anderson, Mechthild Jonas, et al.. (2014). Abstract 2647: SGN-CD70A, a novel and highly potent anti-CD70 ADC, induces double-strand DNA breaks and is active in models of MDR+ renal cell carcinoma (RCC) and non-Hodgkin lymphoma (NHL). Cancer Research. 74(19_Supplement). 2647–2647. 9 indexed citations

Sutherland, May S.K., Roland B. Walter, Scott C. Jeffrey, et al.. (2012). SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML. Blood. 120(21). 3589–3589. 7 indexed citations

Jeffrey, Scott C., Patrick Burke, David W. Meyer, et al.. (2012). Abstract 4631: Anti-CD70 antibody-drug conjugates containing pyrrolobenzodiazepine dimers demonstrate robust antitumor activity. Cancer Research. 72(8_Supplement). 4631–4631. 1 indexed citations

10.

Lewis, Timothy S., et al.. (2011). Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells. Leukemia. 25(6). 1007–1016. 14 indexed citations

11.

McDonagh, Charlotte F., Kristine M. Kim, Eileen Turcott, et al.. (2008). Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index. Molecular Cancer Therapeutics. 7(9). 2913–2923. 60 indexed citations

12.

Oflazoglu, Ezogelin, Ivan J. Stone, Kristine A. Gordon, et al.. (2008). Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable Linker. Clinical Cancer Research. 14(19). 6171–6180. 93 indexed citations

13.

Kim, Kristine M., Charlotte F. McDonagh, Lori Westendorf, et al.. (2008). Anti-CD30 diabody-drug conjugates with potent antitumor activity. Molecular Cancer Therapeutics. 7(8). 2486–2497. 73 indexed citations

14.

Oflazoglu, Ezogelin, Ivan J. Stone, Lindsay L. Brown, et al.. (2008). Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40. British Journal of Cancer. 100(1). 113–117. 60 indexed citations

15.

Gerber, Hans Peter, Ivan J. Stone, Jamie B. Miyamoto, et al.. (2008). 507 POSTER Potent antitumor activity of the anti-CD19 auristatin antibody-drug conjugate hBU12-vcMMAE in rituximab sensitive and resistant lymphomas. European Journal of Cancer Supplements. 6(12). 161–161. 2 indexed citations

16.

Bodensteiner, Karin J., et al.. (2008). Effects of Dehydroepiandrosterone Sulfate and Progesterone on Spatial Learning and Memory in Young and Aged Mice. The Journal of General Psychology. 135(3). 271–286. 3 indexed citations

17.

Gerber, Hans‐Peter, Ivan J. Stone, Mechthild Jonas, et al.. (2007). Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies. Molecular Cancer Therapeutics. 6. 2 indexed citations

18.

Lewis, Timothy S., Kim M. Kissler, Ivan J. Stone, et al.. (2007). The Humanized Anti-CD40 Monoclonal Antibody, SGN-40, Potentiates Chemotherapy Regimens in NHL Xenograft Models Via Pro-Apoptotic Signaling.. Blood. 110(11). 2342–2342. 6 indexed citations

19.

McDonagh, Charlotte F., Eileen Turcott, Lori Westendorf, et al.. (2006). Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment. Protein Engineering Design and Selection. 19(7). 299–307. 182 indexed citations

20.

McEarchern, Julie A., Ezogelin Oflazoglu, Leigh Francisco, et al.. (2006). Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. Blood. 109(3). 1185–1192. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact